Key result
Elevated apoC3 correlates with plaque necrotic core volume and independently predicts 4-year post-PCI major cardiovascular events.
Cohort (n=98)
Answers are grounded in this paper and cite their sources.
Reveals elevated apolipoprotein C3 and plaque necrotic core volume independently predict 4-year major cardiovascular events in stable coronary disease, indicating a biomarker for high-risk lesions.
We aimed to clarify the relationship between apolipoprotein C3 (apo-C3) and vascular composition of lesion plaque in stable coronary disease (SCD) before percutaneous coronary intervention (PCI) and to investigate major adverse cardiovascular events (MACEs) within 4 years. Data of 98 consecutive patients with SCD who underwent PCI between November 1, 2012, and March 10, 2015, were analyzed. Laboratory evaluation and virtual histology-intravascular ultrasound (VH-IVUS) examination of culprit lesions were conducted before PCI. Patients were divided according to the median apo-C3 value into low apo-C3 (≤8.5 mg/dL) and high apo-C3 (>8.5 mg/dL) groups. VH-IVUS data indicated that the percentage of necrotic core volume (%NC) was significantly higher in the high apo-C3 group than in the low apo-C3 group. Moreover, the %NC significantly correlated with the apo-C3 level (R=0.2109, P=0.037). Kaplan–Meier curve analysis revealed that freedom from MACEs decreased more in the high apo-C3 group than in the low apo-C3 group and in the high %NC group than in the low %NC group. Multivariate Cox hazards analysis showed that the %NC and high apo-C3 were independent predictors of 4-year MACEs. Apo-C3 may be a useful marker for future MACEs in patients with SCD after PCI and contribute to %NC growth.
No takes yet. Share an insight, caveat, or question.
Ohwada et al. (2022) conducted a cohort in Stable coronary disease undergoing percutaneous coronary intervention (n=98). High apolipoprotein C3 (>8.5 mg/dL) vs. Low apolipoprotein C3 (≤8.5 mg/dL) was evaluated on Major adverse cardiovascular events (MACEs) within 4 years and percentage of necrotic core volume (%NC) (R=0.2109, p=0.037). Apolipoprotein C3 correlated with plaque necrotic core volume, and high apo-C3 independently predicted 4-year MACEs after PCI.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: